Roivant Sciences Ltd. (ROIV) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Roivant Sciences Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.276 Good day, and thank you for standing by. Welcome to the Roy Vant Third Quarter 2025 00:00:05.276 -- 00:00:09.860 Earnings Conference Call. At this time, all participants are in a listen-only mode. 00:00:09.860 -- 00:00:12.843 After the speaker's presentation, there will be a question and answer session. 00:00:12.843 -- 00:00:18.208 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:18.208 -- 00:00:21.612 You will then hear an automated message advising your hand is raised. 00:00:21.612 -- 00:00:23.934 To withdraw your question, please press star 11 again. 00:00:23.934 -- 00:00:27.824 Please be advised that today's conference is being recorded. 00:00:27.824 -- 00:00:31.048 I would now like to hand the conference over to your speaker today, Stephanie Lee. 00:00:31.048 -- 00:00:33.351 Please go ahead. 00:00:33.351 -- 00:00:36.915 Good morning, and thanks for joining today's call to review positive phase two results 00:00:36.915 -- 00:00:41.320 for brevacitinib and cutaneous sarcoidosis, and Reuven's financial results for the third 00:00:41.320 -- 00:00:45.245 quarter ended December 31, 2025. I'm Stephanie Lee with Reuven. 00:00:45.245 -- 00:00:49.730 Presenting today, we have Matt Klein, CEO of Reuven, and Ben Zimmer, CEO of Reuven. 00:00:49.730 -- 00:00:53.074 For those dialing in via conference call, you can find the slides being presented today 00:00:53.074 -- 00:00:58.812 as well as the press release announcing these updates on our IR website at www.investor.royvand.com. 00:00:59.956 -- 00:01:04.241 We'll also be providing the current slide numbers as we present to help you follow along. 00:01:04.241 -- 00:01:07.165 I would like to remind you that we will be making certain forward-looking...